Secondary Hyperpigmentation During Interferon Alfa Treatment for Chronic Hepatitis C Virus Infection

• Autores: Katerina Tsilika, Albert Tran
• Localización: JAMA Dermatology, ISSN 2168-6068, Vol. 149, Nº. 6, 2013, págs. 675-677
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Importance Interferon alfa remains the central treatment for chronic hepatitis C virus (HCV) infection. Cases of cutaneous and mucous hyperpigmentations during interferon alfa treatment have been reported, but they are considered rare adverse effects.

    Objective To study the clinical presentation and frequency of hyperpigmentation in patients receiving interferon alfa treatment for chronic HCV infection.